Literature DB >> 50872

Comparison of alpha1 fetoprotein radioimmunoassay method and liver scanning for detecting primary hepatic cell carcinoma.

N Tonami, T Aburano, K Hisada.   

Abstract

Alpha1 (alpha 1) fetoprotein (AFP) radioimmunoassay method was routinely used in addition to liver scintigraphy to detect a primary hepatic cell carcinoma, and the diagnostic accuracy of both methods was compared. Twenty-one of 27 cases (78%) with primary hepatic cell carcinoma showed a positive AFP titer of over 200 ng/ml. In 3 of these AFP-positive cases, no focal defects could be found in liver scintigraphy, although subsequently performed celiac angiography revealed hypervascular shadows. On the contrary, 22 of 27 cases (81%) represented well-defined focal defects on scintigraphy. In 4 of these cases with a positive scan, the result of AFP was found to be negative. The overall diagnostic accuracy for detecting primary hepatic cell carcinoma with a combination of both methods was 93%.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 50872     DOI: 10.1002/1097-0142(197508)36:2<466::aid-cncr2820360224>3.0.co;2-u

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Minute liver cancer and concomitant esophageal varices: detection and successful surgical treatment.

Authors:  T Kanematsu; K Sugimachi; H Kohno; T Matsumata; M Kobayashi; K Inokuchi
Journal:  World J Surg       Date:  1981-09       Impact factor: 3.352

2.  Radioimmunoassay for carcinoembryonic antigen and alpha 1-fetoprotein in the qualitative evaluation of focal hepatic lesions in Japan.

Authors:  T Aburano; N Tonami; A Tada; K Hisada
Journal:  Eur J Nucl Med       Date:  1980-08

3.  Computed tomography in the detection of small hepatocellular carcinomas.

Authors:  K Inamoto; S Tanaka; H Yamazaki; E Okamoto
Journal:  Gastrointest Radiol       Date:  1983

Review 4.  Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma.

Authors:  Stijn Van Hees; Peter Michielsen; Thomas Vanwolleghem
Journal:  World J Gastroenterol       Date:  2016-10-07       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.